054950.KQ JVM Co. Ltd
- Market cap
- KRW 267B
- P/E
- 8.4x
- P/B
- 1.09x
- ROE
- 15.6%
- Dividend yield
- 2.16%
- Fundamental score
- 3.0/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 054950.KQ undervalued?
Graham number054950.KQ trades 36.2% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
JVM Co. Ltd fundamental analysis
16 of 22 checks passedROE 1/2
Moderate return on equity (15.6%), between 10% and 20%.
ROA 1/1
Return on assets (11.4%) is above the industry median (2.7%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-1.7%) is not above the 5-year average (22.1% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (-1.7%) is above the industry median (-4.2%).
Revenue Growth 1/2
Revenue grew 6.8% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
No interest expense reported.
PE vs Market 1/1
PE (8.4x) is below the market median (11.3x).
PE vs Industry 0/1
PE (8.4x) is above the industry median (7.7x).
PBV 0/1
Price to book (1.1x) is above the industry median (0.8x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 9.2, limit 22.5).
PEG 1/1
PEG on 5-year earnings growth is 0.38, growth is cheap.
Dividend Yield 1/2
Dividend yield (2.2%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 1/2
Dividends paid without a cut of more than 10% for 9 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 20.3%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
JVM Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About JVM Co. Ltd
JVM Co., Ltd. develops and sells automation systems and software of dispensing, packaging, and medication management for hospitals and pharmacies worldwide. It offers automatic dispensing and packaging systems; medication inspection and winding systems; medicine counting systems; canister management systems; automatic tablet counting systems; automatic tablet cutting systems; automatic PTP deblisters; special shape tablets pre-preparation systems; automatic pouch rolling sys…
Full company profileJVM Co. Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
JVM Co. Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 98.1B | 106B | 104B | 110B | 115B | 116B | 142B | 157B | 159B | 173B | 190B |
| Gross Profit | 42.6B | 45.1B | 40.2B | 39.1B | 42.0B | 39.2B | 51.2B | 62.6B | 63.7B | 70.8B | 83.7B |
| Operating Income | 11.8B | 11.8B | 9.28B | 5.94B | 12.9B | 11.2B | 20.0B | 29.8B | 30.7B | 33.3B | 45.6B |
| EBITDA | - | - | - | - | - | - | 26.5B | 39.3B | 40.9B | 42.0B | 53.3B |
| Net Income | 11.1B | 11.5B | 8.16B | 5.80B | 10.4B | 8.95B | 15.8B | 26.2B | 28.8B | 28.4B | 38.3B |
| EPS | 912 | 948 | 687 | 497 | 907 | 777 | 1,368 | 2,278 | 2,504 | 2,461 | 3,329 |
| Balance Sheet | |||||||||||
| Total Assets | 177B | 172B | 177B | 180B | 200B | 211B | 232B | 258B | 285B | 319B | 337B |
| Total Liabilities | 64.5B | 51.3B | 53.6B | 56.5B | 62.6B | 67.6B | 73.6B | 78.0B | 82.5B | 85.2B | 90.8B |
| Shareholders' Equity | 112B | 121B | 123B | 124B | 137B | 143B | 158B | 179B | 202B | 234B | 246B |
| Cash & Short-term Investments | 26.0B | 15.7B | 21.9B | 27.4B | 39.3B | 54.5B | 67.7B | 88.3B | 106B | 8.67B | 15.4B |
| Total Debt | 40.2B | - | - | 18.8B | 26.1B | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 14.9B | 18.0B | 19.9B | 18.6B | 19.8B | 26.1B | 14.8B | 29.9B | 25.9B | 30.4B | 47.2B |
| Capital Expenditure | 8.32B | 6.27B | 4.44B | 4.76B | 7.12B | 5.12B | 4.70B | 3.29B | 3.67B | 4.87B | 5.93B |
| Free Cash Flow | - | - | - | - | 10.7B | 21.0B | 10.1B | 26.6B | 22.3B | 25.5B | 41.3B |
| Ratios | |||||||||||
| ROE | 9.9% | 9.5% | 6.6% | 4.7% | 7.6% | 6.2% | 10.0% | 14.6% | 14.3% | 12.1% | 15.6% |
| ROA | 6.3% | 6.6% | 4.6% | 3.2% | 5.2% | 4.2% | 6.8% | 10.2% | 10.1% | 8.9% | 11.4% |
| Net Profit Margin | 11.3% | 10.8% | 7.9% | 5.3% | 9.0% | 7.7% | 11.1% | 16.7% | 18.1% | 16.4% | 20.2% |
| Debt to Equity | 0.36x | - | - | 0.15x | 0.19x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
JVM Co. Ltd dividends
- Dividend yield
- 2.16%
- Forward dividend
- 650.00 KRW
- Payout ratio
- 20.3%
- Ex-dividend date
- Dec 29, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 5.76B | 500 | 20.3% |
| 2024 | KRW 4.61B | 400 | 16.0% |
| 2023 | KRW 3.46B | 300 | 13.2% |
| 2022 | KRW 2.30B | 200 | 14.6% |
| 2021 | KRW 2.30B | 200 | 25.7% |
| 2020 | KRW 2.34B | 203 | 22.4% |
| 2019 | KRW 2.08B | 178 | 35.8% |
| 2018 | KRW 1.81B | 153 | 22.2% |
| 2017 | KRW 608M | 50 | 5.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Mar 30, 2021.
Who owns JVM Co. Ltd
- Insiders 39.21%
- Institutions 14.29%
- Public & others 46.50%
- Shares outstanding 11.5M
- Free float 6.79M
JVM Co. Ltd company profile
- Company name
- JVM Co. Ltd
- Ticker
- 054950.KQ
- ISIN
- KR7054950001
- Exchange
- KOSDAQ
- Listed since
- Jun 7, 2006
- Sector
- Healthcare
- Industry
- Machinery
- Employees
- 307
- Fiscal year end
- December
- Address
- 121, Hosandong-ro, Daegu, South Korea, 42709
- Phone
- 82 5 3584 9999
- Website
- myjvm.com
About JVM Co. Ltd
JVM Co., Ltd. develops and sells automation systems and software of dispensing, packaging, and medication management for hospitals and pharmacies worldwide. It offers automatic dispensing and packaging systems; medication inspection and winding systems; medicine counting systems; canister management systems; automatic tablet counting systems; automatic tablet cutting systems; automatic PTP deblisters; special shape tablets pre-preparation systems; automatic pouch rolling systems; DOB blister paper sealing guides; and automated medication management systems. The company also provides OnCube Management for dispensing, packaging, and medication management; Check VIZEN, a pouch inspection and management software; STS Load Station, an STS pre-packaging software; INTIPharm Management, a medication management software; INTIPharm Notifier, a medication management alert software; INTIPharm Transfer Check, a medication management transfer software; and INTIPharm Secusion Viewer, a medication management image viewer software. In addition, it is involved in the sales of automatic drug sorting and packaging systems. The company was formerly known as JVMedi and changed its name to JVM Co., Ltd. in April 2004. JVM Co., Ltd. was founded in 1977 and is headquartered in Daegu, South Korea.
JVM Co. Ltd management
3- Dong-hwan LeeCEO & Executive Director · born 1969
- Mr. Yong-Hee LeePresident
- Sung-jin ParkAssistant Executive Director